Skip to Navigation Skip to Search Skip to Content
Search All Centers

The Leading Edge of MPN Treatment

Log in and Register Become a Member and Register


The tide of new information can be overwhelming. Join us for our next Answers Now: Facing MPNs program on Wednesday, September 30th at 1:30 pm PT/3:30 pm CT/4:30 pm ET to get a clear, succinct picture of what you need to know.

Hosts Ruth Fein and co-host Andrew Schorr will talk to Dr. Srdan Verstovsek, Professor of Medicine and a hematologist-oncologist at The University of Texas MD Anderson Cancer Center, about recent research leading to new therapies and new understandings of myeloproliferative neoplasms (MPNS) including detailed information about potential new treatments for essential thrombocythemia (ET), polycythemia vera (PV) and myelofibrosis (MF). As a number of clinical trials move through Phase Three, there are new therapies and more FDA approvals are on the horizon. There are many new treatment options to get excited about.

Get your questions answered live or send them in ahead of the program to

This program is sponsored by Incyte. This organization has no editorial control. It is produced by Patient Power in partnership with the MPN Research Foundation. Patient Power is solely responsible for program content.

Hosts and Guests

Ruth Fein


Ruth Fein

MPN Patient Advocate

Andrew Schorr


Andrew Schorr

Host, Patient Power Co-Founder, Two-Time Cancer Survivor and Patient Advocate

Srdan Verstovsek,  MD, PhD


Srdan Verstovsek MD, PhD

Director, Clinical Research Center for MPN, Department of Leukemia; The University of Texas MD Anderson Cancer Center


Already have an account? Login and register

Required field. Minimum 8 characters.
Required field.